
QIAGEN N.V. QGEN
Annual report 2025
added 04-04-2026
QIAGEN N.V. Depreciation & Amortization 2011-2026 | QGEN
Annual Depreciation & Amortization QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 194 M | 203 M | 205 M | 208 M | 215 M | 205 M | 231 M | 206 M | 216 M | 213 M | 191 M | 201 M | 199 M | 198 M | 167 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 231 M | 167 M | 204 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
321 M | $ 118.25 | -1.27 % | $ 35.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 22.5 | 9.44 % | $ 242 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 22.42 | 27.6 % | $ 1.19 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 1.46 | 2.82 % | $ 1.94 M | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
16 M | $ 24.56 | -0.24 % | $ 682 M | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 176.94 | -2.0 % | $ 8.77 B | ||
|
Danaher Corporation
DHR
|
750 M | $ 193.78 | -2.18 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
354 M | $ 132.72 | 0.35 % | $ 21.1 B | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 16.13 | -0.25 % | $ 488 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 515.65 | -0.56 % | $ 14.9 B | ||
|
Guardant Health
GH
|
39.7 M | $ 85.7 | 0.99 % | $ 10.7 B | ||
|
Anixa Biosciences
ANIX
|
38.3 K | $ 2.83 | -3.41 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
87 K | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 115.58 | -0.79 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 266.36 | -0.14 % | $ 22.2 B | ||
|
Celcuity
CELC
|
167 K | $ 125.25 | 1.44 % | $ 5.86 B | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 83.92 | -0.02 % | $ 5.66 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 5.0 | -3.66 % | $ 463 M | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.16 | -5.99 % | $ 1.05 B | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.24 | -1.91 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 191.46 | 0.02 % | $ 21.3 B | ||
|
ENDRA Life Sciences
NDRA
|
44 K | $ 5.17 | 0.58 % | $ 4.07 M | ||
|
National Research Corporation
NRC
|
7.62 M | $ 17.62 | -1.23 % | $ 394 M | ||
|
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | ||
|
Natera
NTRA
|
16.7 M | $ 196.11 | -5.35 % | $ 19.3 B | ||
|
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
405 M | - | -0.91 % | $ 14.7 B |